Placement of Nine Specific Fentanyl Related Substances in Schedule I (DEA1036)
2023-04-18 2023-05-17 2023-05-01 2023-05-17 2023-05-17 2023-05-17 2023-05-17
DEA-2023-0058-0005 DEA-2023-0058-0011 DEA-2023-0058-0006 DEA-2023-0058-0008 DEA-2023-0058-0009 DEA-2023-0058-0007 DEA-2023-0058-0010
04:00:00 04:00:00 04:00:00 04:00:00 04:00:00 04:00:00 04:00:00
https://api.regulations.gov/v4/comments/DEA-2023-0058-0005 https://api.regulations.gov/v4/comments/DEA-2023-0058-0011 https://api.regulations.gov/v4/comments/DEA-2023-0058-0006 https://api.regulations.gov/v4/comments/DEA-2023-0058-0008 https://api.regulations.gov/v4/comments/DEA-2023-0058-0009 https://api.regulations.gov/v4/comments/DEA-2023-0058-0007 https://api.regulations.gov/v4/comments/DEA-2023-0058-0010
Dazi Anonymous Anonymous Anonymous Anonymous Anonymous Anonymous
Psurny Anonymous Anonymous Anonymous Anonymous Anonymous Anonymous
When looking at the schedule requirements, and the eight different factors going into what places a drug into a schedule, I believe that fentanyl should be placed in schedule 1. The fact that marijuana is classified as a schedule 1 drug, but not fentanyl blows my mind. Marijuana deaths are extremely low and not as likely to happen, whereas fentanyl deaths are on the rise, and thousands have suffered from it. Loved ones have lost family members to this drug which is why it should be classified as a schedule 1 drug. The risk to the public health, the potential for abuse, and dependency alone should classify it as a schedule 1 drug. Instead of extending the rule to December 31, 2024, put fentanyl as a schedule 1 drug today. The Drug Enforcement Administration (DEA proposes to permanently schedule the following nine controlled substances in schedule I of the Controlled Substances Act (CSA). The nine specific fentanyl-related substances are: (1) Meta-fluorofentanyl, (2) Meta-fluoroisobutyryl fentanyl, (3) Para-methoxyfuranyl fentanyl, (4) 3-furanyl fentanyl, (5) 2,5-dimethoxyfentanyl, (6) isovaleryl fentanyl, (7) ortho-fluorofuranyl fentanyl, (8) alpha-methyl butyryl fentanyl, and (9) andpara-methylcyclopropyl fentanyl. I agree that Drug Enforcement Administration should make the nine Fentanyl-related substance listed under the category of Schedule I drugs permanent instead of constantly extending the temporary order multiple times. First it started on February 6, 2018, then two years later February 6, 2020. Then the Congress extended until May 6, 2021, after it was extended on December 29, 2021, and now the order was extended until December 31, 2024. After the extended order expires on December 31, 2024, this order should be made permanent, honestly, it shouldve been made permanent already. By finalized this rule, the federal law can act against the people who are handling these nine specifics fentanyl substance. Over 150 people die every day from fentanyl-related drug overdoses. I think it is time to take action against this fatal drug.  The designation of Nine specific Fentanyl related substances to Schedule I of the Controlled Substance Act should be made permanent after the temporary scheduling order expires on December 31, 2024. Fentanyl-related drug overdoses have been increasing throughout the US according to the National Institute on Drug Abuse. The Proposed rule states in the background information that these substances pose an imminent hazard to public safety, as citizens we see this news daily about the effects of fentanyl in communities across the country. In section 1 (a) the criteria for the potential of abuse is described through evidence that taking the drug will create a hazard to their health or to the safety of others in the community, it is clearly a hazard because of all the deaths that have been occurring due to Fentanyl overdose and the destruction it is causing in communities. Fentanyl and the list of related substances listed in the Rule being in a category of Schedule I drugs would allow for regulation of the substances and improve the Publics Health from the negative effects of this drug. DiscussionNine drugs are being suggested to be added to Schedule I of the Controlled Substances Act by the Drug Enforcement Administration (DEA). These substances are stated in the suggested regulation. The nine drugs all fulfill the criteria for fentanyl-related compounds defined in the interim scheduling directive from February 6, 2018. The Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act stretched the power until December 31, 2024, and the Consolidated Appropriations Act of 2023 expanded it. If adopted, the proposed measure would irrevocably limit the nine particular compounds and impose punishments on any person found in the ownership of, manufacturing, importing, exporting, engaging in academic study, conducting chemical examinations, importing, or managing them in any other manner.Direct and indirect effects on federal-state healthcare would result from the policy as mentioned above. Directly stated, it would boost federal oversight of manufacturing and disseminating possibly harmful chemicals, limiting their availability and expected abuse (Pardo et al., 2023). Furthermore, it would keep these drugs off the black market, giving the federal level greater assurance to administer and utilize drugs. By demonstrating the federal governments commitment to ensuring the well-being and protection of its residents, the policy move would help significantly increase public confidence in the medical field.I support the suggested regulation in its entirety. The federal level must have a role in reducing the consumption of such drugs in a society where opioids are putting an ever-increasing strain on medical care. Rigorous regulatory oversight and criminal penalties for perpetrators will guarantee that authorities can effectively administer the law. It is critical to restrict the utilization of fentanyl replicates to people who need them for serious medical needs. Establishing a regular schedule, I classification for these medicines aids in ensuring that they are applied prudence and remain accessible for recognized medical purposes. Furthermore, raising public knowledge of the risks of abusing these drugs benefits their prevention. The suggestion is in line with this requirement and ought to be accepted.ReferencePardo, B., Kilmer, B.,  Taylor, J. (2023). Illegal Supply and Supply Control. AMERICAS OPIOID ECOSYSTEM, 273. https://www.jcoinctc.org/wp-content/uploads/RAND_Americas-Opioid-Ecosystem_2023.pdf#page=295 The proposed regulation by the Drug Enforcement Agency (DEA) would permanently classify nine fentanyl-related substances as schedule 1 drugs. These substances were placed on a temporary schedule since February 6, 2018, and since then has been extended multiple times by Congress. However, this temporary order will expire on December 31, 2024, but the DEA is hoping to classify it as schedule 1 permanently thereafter. This would keep in place all regulations and law pertaining to how schedule 1 substances are handled, distributed, manufactured, or sold by anyone who handles the drug whether for illegal purposes or not.This will affect healthcare on a federal level because the ongoing opioid crisis has seen multiple agencies across the government trying to bring this public health crisis under control. There were about 1,550 pediatric deaths from fentanyl in 2021  over 30 times more than in 2013, when the wave of overdose deaths involving synthetic opioids started in the US. A surge that began in 2018 led to a nearly 3-fold increase in deaths among older adolescents and a nearly 6-fold increase among children younger than 5. In 2021, 40 infants and 93 children ages 1 to 4 died from a fentanyl overdose (McPhillips, 2023). There are no reasons that children or anyone should be exposed to this drug because even a small amount can be deadly.I would have to agree with this proposed regulation of classifying fentanyl-related substances as a schedule 1 drug with the ongoing epidemic of the opioid crisis that has grip the nation. Fentanyl is highly addictive being 50 to 100 times more potent than morphine (Fentanyl Drugfacts, 2023). While prescription fentanyl is given to some patients who have chronic pain or have had major surgery other alternative medications should be prescribed first leaving fentanyl as a last resort. While theres an understanding that we will probably never get rid of substances such as fentanyl at least people might think twice about distributing it to others because it is such a highly addictive drug.ReferenceMcPhillips, D. (2023, May 8). Fentanyl-related deaths among children increased more than 30-fold between 2013 and 2021. CNN. https://www.cnn.com/2023/05/08/health/fentanyl-overdose-deaths-children/index.html U.S. Department of Health and Human Services. (2023, March 3). Fentanyl drugfacts. National Institutes of Health. https://nida.nih.gov/publications/drugfacts/fentanyl  The topic being proposed is the placement of nine fentanyl-related substances into Schedule I of the Controlled Substances Act. This proposal aims to combat the growing opioid epidemic in the United States by making it more difficult to produce and distribute these dangerous substances.According to a news article by NPR, these nine fentanyl-related substances are not currently classified as controlled substances, which makes it easier for manufacturers to produce and distribute them without facing legal consequences. However, the proposed ruling would add these substances to Schedule I, which is reserved for drugs with a high potential for abuse and no accepted medical use.At the federal level, this proposal could have significant impacts on the healthcare industry. It could lead to increased regulation and oversight of fentanyl-related substances, which could help prevent the misuse and abuse of these drugs. However, it could also make it more difficult for medical professionals to access these substances for legitimate medical purposes, which could potentially harm patients in need of pain management.Overall, I agree with the proposed ruling to add these nine fentanyl-related substances to Schedule I. The opioid epidemic in the United States has had devastating effects on communities across the country, and it is important to take strong measures to combat it. While there may be some challenges associated with increased regulation of these substances, I believe the potential benefits outweigh the potential drawbacks. The Drug Enforcement Administration (DEA proposes to permanently schedule the following nine controlled substances in schedule I of the Controlled Substances Act (CSA). The nine specific fentanyl-related substances are: (1) Meta-fluorofentanyl, (2) Meta-fluoroisobutyryl fentanyl, (3) Para-methoxyfuranyl fentanyl, (4) 3-furanyl fentanyl, (5) 2,5-dimethoxyfentanyl, (6) isovaleryl fentanyl, (7) ortho-fluorofuranyl fentanyl, (8) alpha-methyl butyryl fentanyl, and (9) andpara-methylcyclopropyl fentanyl. I agree that Drug Enforcement Administration should make the nine Fentanyl-related substance listed under the category of Schedule I drugs permanent instead of constantly extending the temporary order multiple times. First it started on February 6, 2018, then two years later February 6, 2020. Then the Congress extended until May 6, 2021, after it was extended on December 29, 2021, and now the order was extended until December 31, 2024. After the extended order expires on December 31, 2024, this order should be made permanent, honestly, it shouldve been made permanent already. By finalized this rule, the federal law can act against the people who are handling these nine specifics fentanyl substance. Over 150 people die every day from fentanyl-related drug overdoses. I think it is time to take action against this fatal drug. 